The disease burden of hepatitis B in Uzbekistan

Journal of Infection

Volumn 40, Issue 3, 2000, Pages 234-241

  Beutels, P ^a   Musabaev, E I ^b   Van Damme, P ^a   Yasin, T ^c  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Epidemiol Microbiol Infect D   (Uzbekistan)

^c Clinical and Medical affairs Biologicals South East Asia and Middle East   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEPATITIS; ARTICLE; CHRONIC HEPATITIS; DISEASE MODEL; DISEASE SIMULATION; EVOLUTION; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; NEWBORN; NEWBORN INFECTION; NEWBORN MORTALITY; UZBEKISTAN;

EID: 0033934795     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.1998.0666     Document Type: Article

References (22)

1. Kane MA, Clements J, Hu D. Hepatitis B. Jamison DT, Mosley WH, Measham AR, Bobadilla J. Disease control priorities in developing countries. A World Bank Book. 1993;321-330 Oxford University Press, New York.
2. Nisini R, Rizzetto M. Clinical types of HBsAg-positive hepatitis. Vaccine. 11:1993;511-515.
3. Bohran-Manesh F. Nomenclature of chronic hepatitis: a plea for change. Scand J Gastroenterol. 29:1994;193-194.
4. Beutels Ph, Tormans G, Van Damme P, Van Doorslaer E. Universal hepatitis B vaccination in Flanders: cost-effective? Tijdschrift voor Sociale Gezondheidszorg. 74:1996;272-281.
5. McMahon BJ, Alward WLM, Hall DB. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis. 151:1985;604-609.
6. Shapiro CN. Epidemiology of hepatitis B. Pediatr Infect Dis J. 12:1993;443-447.
7. Edmunds WJ, Medley GF, Nokes DJ, Hall AJ, Whttle HC. The influence of age on the development of the hepatitis B carrier state. Proc R Soc Lond. 253:1993;197-201.
8. Sinatra FR, Shah P, Weissman JY, Thomas DW, Merritt RJ, Tong MJ. Perinatal transmitted acute icteric hepatitis B in infants born to hepatitis B surface antigen-positive and anti-hepatitis B 'e'-positive carrier mother. Pediatrics. 70:1982;557-559.
9. Delaplane D, Yogev R, Crussi F, Shulman ST. Fatal hepatitis B in early infancy: the importance of identifying HBsAg-positive pregnant women and providing immunoprophylaxis to their newborns. Pediatrics. 72:1983;176-180.
10. Van Damme P. Hepatitis B: Epidemiology and Evaluation of Vaccination. 1994;University of Antwerp, Antwerp. p. 245.
11. Seeff LB, Beebe GW, Hoofnagle JH. A serological follow-up of the 1942 epidemic of post vaccination hepatitis in the United States Army. N Engl J Med. 316:1987;965-970.
12. Tassopoulos NC, Papaevengelou GJ, Sjogren MH, Roumeliotou-Karayannis A, Gerin JL, Purcell RH. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology. 92:1987;1844-1850.
13. Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B - a meta analysis. Ann Intern Med. 119:1993;312-323.
14. Sherlock S. Hepatitis B: the disease. Vaccine. 8:1990;6-9.
15. Sherlock S. The natural history of hepatitis B. Postgr Med J. 63:1987;7-11.
16. MMWR. 39:1990;5-22.
17. Wright TL, Lau JYN. Clinical aspects of hepatitis B virus infection. Lancet. 342:1993;1340-1344.
18. Fattovich G, Brollo L, Giustina G. Natural history and prognostic factors for chronic hepatitis type B. Gut. 32:1991;294-298.
19. De Jongh FE, Janssen HLA, De Man RA. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology. 103:1992;1630-1635.
20. Realdi G, Fattovich G, Hadziyannis S. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. J Hepatol. 21:1994;656-666.
21. UNDP, United Nations Development Report, 1997.
22. Viral Hepatitis Prevention Board (VHPB), David, FitzSimonsPierre, Van Damme, Prevention and Control of Hepatitis B in Central and Eastern Europe and the Newly Independent States.